NEOSTIGMINE METHYLSULFATE — all Canadian products
23 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NEOSTIGMINE METHYLSULFATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02475499 | NEOSTIGMINE METHYLSULFATE INJECTION USP | MARCAN PHARMACEUTICALS INC | Solution | Subcutaneous; Intramuscular; Intravenous | NEOSTIGMINE METHYLSULFATE 1 MG | Marketed | |
| 02497786 | NEOSTIGMINE METHYLSULFATE INJECTION USP | STERIMAX INC | Solution | Subcutaneous; Intramuscular; Intravenous | NEOSTIGMINE METHYLSULFATE 1 MG | Approved | |
| 02497778 | NEOSTIGMINE METHYLSULFATE INJECTION USP | STERIMAX INC | Solution | Intravenous; Intramuscular; Subcutaneous | NEOSTIGMINE METHYLSULFATE 0.5 MG | Approved | |
| 02475480 | NEOSTIGMINE METHYLSULFATE INJECTION USP | MARCAN PHARMACEUTICALS INC | Solution | Subcutaneous; Intramuscular; Intravenous | NEOSTIGMINE METHYLSULFATE 0.5 MG | Marketed | |
| 02537516 | NEOSTIGMINE METHYLSULFATE INJECTION, USP | JAMP PHARMA CORPORATION | Solution | Subcutaneous; Intramuscular; Intravenous | NEOSTIGMINE METHYLSULFATE 0.5 MG | Marketed | |
| 02230593 | NEOSTIGMINE OMEGA | OMEGA LABORATORIES LIMITED | Liquid | Intravenous; Subcutaneous; Intramuscular | NEOSTIGMINE METHYLSULFATE 0.5 MG | Marketed | |
| 02387166 | NEOSTIGMINE OMEGA | OMEGA LABORATORIES LIMITED | Solution | Subcutaneous; Intravenous; Intramuscular | NEOSTIGMINE METHYLSULFATE 2.5 MG | Marketed | |
| 02230592 | NEOSTIGMINE OMEGA | OMEGA LABORATORIES LIMITED | Liquid | Subcutaneous; Intravenous; Intramuscular | NEOSTIGMINE METHYLSULFATE 1 MG | Marketed | |
| 01914588 | NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intramuscular; Intravenous; Subcutaneous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Post Market | |
| 02243103 | NEOSTIGMINE METHYLSULFATE INJECTION | FRESENIUS KABI CANADA LTD | Liquid | Subcutaneous; Intramuscular; Intravenous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Pre Market | |
| 02243104 | NEOSTIGMINE METHYLSULFATE INJECTION | FRESENIUS KABI CANADA LTD | Liquid | Subcutaneous; Intravenous; Intramuscular | NEOSTIGMINE METHYLSULFATE 0.5 MG | Cancelled Pre Market | |
| 02385201 | NEOSTIGMINE METHYLSULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous; Intramuscular | NEOSTIGMINE METHYLSULFATE 0.5 MG | Cancelled Pre Market | |
| 02385228 | NEOSTIGMINE METHYLSULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous; Intramuscular | NEOSTIGMINE METHYLSULFATE 2.5 MG | Cancelled Pre Market | |
| 00885282 | NEOSTIGMINE METHYLSULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | Intramuscular; Subcutaneous; Intravenous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Post Market | |
| 01915436 | NEOSTIGMINE METHYLSULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Subcutaneous; Intravenous | NEOSTIGMINE METHYLSULFATE 2.5 MG | Cancelled Post Market | |
| 00874957 | NEOSTIGMINE METHYLSULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intravenous; Intramuscular | NEOSTIGMINE METHYLSULFATE 0.5 MG | Cancelled Post Market | |
| 02546191 | NEOSTIGMINE METHYLSULFATE INJECTION, USP | JUNO PHARMACEUTICALS CORP. | Solution | Intravenous; Subcutaneous; Intramuscular | NEOSTIGMINE METHYLSULFATE 2.5 MG | Cancelled Pre Market | |
| 02546175 | NEOSTIGMINE METHYLSULFATE INJECTION, USP | JUNO PHARMACEUTICALS CORP. | Solution | Intravenous; Intramuscular; Subcutaneous | NEOSTIGMINE METHYLSULFATE 0.5 MG | Cancelled Pre Market | |
| 02546183 | NEOSTIGMINE METHYLSULFATE INJECTION, USP | JUNO PHARMACEUTICALS CORP. | Solution | Intramuscular; Intravenous; Subcutaneous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Pre Market | |
| 00868930 | PMS-NEOSTIGMINE METHYLSULFATE INJ 1MG/ML | PHARMASCIENCE INC | Liquid | Intramuscular; Intravenous; Subcutaneous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Post Market | |
| 00869929 | PROSTIGMIN INJ 1:1000 USP | ICN CANADA LTD. | Liquid | Intramuscular; Intravenous; Subcutaneous | NEOSTIGMINE METHYLSULFATE 1 MG | Cancelled Post Market | |
| 00869937 | PROSTIGMIN INJ 1:400 USP | ICN CANADA LTD. | Solution | Intravenous; Intramuscular; Subcutaneous | NEOSTIGMINE METHYLSULFATE 2.5 MG | Cancelled Post Market | |
| 00564508 | STIMULINE INJ 2MG/ML | DISTRIVET INC. | Liquid | Subcutaneous; Intramuscular | NEOSTIGMINE METHYLSULFATE 2 MG | Cancelled Post Market |
Browse other molecules: